PER 4.94% 8.5¢ percheron therapeutics limited

Impressive, page-62

  1. 3,061 Posts.
    lightbulb Created with Sketch. 548
    The issue of shares to Australian Ethical Investment is conditional on the Company receiving hospital approval any time before 30 September 2017 to commence the clinical trial for ATL 1102 in DMD.

    The entire board with all their so called experience cant even get this over the line.
    Pathetic & useless.!!!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.